Premium
Options for Immunocontraception and Issues to be Addressed in the Development of Birth Control Vaccines
Author(s) -
GRIFFIN P. D.
Publication year - 1992
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1992.tb01632.x
Subject(s) - human reproduction , biology , human chorionic gonadotropin , fertility , immunology , pregnancy , bioinformatics , medicine , population , genetics , environmental health
Although the number of family planning methods currently available to couples has never been greater, the range and type of options are still not adequate to meet the widely varying personal needs and demands of individuals worldwide. Birth control vaccines offer a number of theoretical attractions although the development, preclinical and clinical testing of such vaccines pose a number of unique problems requiring novel solutions. If the on‐going studies in this area are successful, a valuable new family planning method may be available by the end of the current decade.